Suspension of trading
Quotes Merrimack Pharmaceuticals
Stocks
MACK
US5903282094
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
21:00:00 17/05/2024 BST
|
5-day change | 1st Jan Change | ||
| 15.13 USD | -0.13% |
|
-.--% | - |
| 20/05/24 | Merrimack Pharmaceuticals, Inc.(NasdaqGM:MACK) dropped from S&P Global BMI Index | CI |
| 20/05/24 | Merrimack Pharmaceuticals, Inc.(NasdaqGM:MACK) dropped from S&P TMI Index | CI |
Stock exchange
Nasdaq
MACK 15.13 $
-0.13%
19M
$
| Markets | Price | Change | Volumes |
|---|
Performance
| 1 day | -0.13% | ||
| 3 years | +23.71% | ||
| 5 years | +226.78% | ||
| 10 years | -66.00% |
Volumes
marketsCapital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
223,748,022
Net sales ()
-
Number of employees
27
Sales / Employee ()
0
Sales / Employee (USD)
0
Free-Float
98.81 %
Free-Float capitalization (USD)
221,082,736
Indicators
Moving average 5 days
15.13
Moving average 100 days
14.3
Price spread / (MMA5)
-0.03%
Price spread / (MMA100)
-5.49%
STIM
RSI 9 days
0
RSI 14 days
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.13% | -.--% | -.--% | +23.71% | 224M | |
| -0.56% | -8.30% | -5.88% | +10.58% | 46.38B | |
| -2.08% | -2.81% | +396.70% | +533.09% | 44.51B | |
| +0.12% | -2.48% | +35.68% | +20.50% | 42.3B | |
| -2.62% | -5.52% | -2.66% | +77.44% | 39.91B | |
| -1.26% | -2.95% | +12.00% | +40.55% | 32.79B | |
| +0.16% | -2.27% | - | - | 17.13B | |
| -0.54% | -1.66% | +20.09% | +115.10% | 16.36B | |
| -0.03% | -2.56% | +10.88% | +30.90% | 14.31B | |
| -1.92% | -6.43% | +73.47% | +36.68% | 13.29B | |
| Average | -0.89% | -2.76% | +60.03% | +98.73% | 26.72B | |
| Weighted average by Cap. | -1.09% | -3.25% | +82.55% | +129.26% |
Historical Quotes: Merrimack Pharmaceuticals
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 3 years | 12 |  | 15.89 |
| 5 years | 3 | | 15.89 |
| 10 years | 1.49 | | 67.9 |
Monthly variations
Annual variations
| 2024 | +12.83% | ||
| 2023 | +17.02% | ||
| 2022 | +193.09% | ||
| 2021 | -43.25% | ||
| 2020 | +118.73% | ||
| 2019 | -18.39% | ||
| 2018 | -62.34% | ||
| 2017 | -74.88% | ||
| 2016 | -48.35% | ||
| 2015 | -30.09% | ||
| 2014 | +111.97% | ||
| 2013 | -12.46% | ||
| 2012 | +0.83% |
- Stock Market
- Stocks
- MACK Stock
- Quotes Merrimack Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
